While this activation marker returned to baseline on Day 14 for CD8+ and non‐regulatory CD4+ T cells, dual expression of ICOS+/PD1+ Tregs was reduced 0.73‐fold (p = 0.0474) (Figure 6k), which also indicates a more immunostimulatory tumor microenvironment. This evidence concerns the gene ICOS and neoplasm.